AJP - Lung Cellular and Molecular Physiology, Vol 260, Issue 6 501-L509, Copyright © 1991 by American Physiological Society

ARTICLES

Isolation of an inhibitor of neutrophil function from bronchial lavage of normal volunteers

J. A. Cooper Jr, Y. Sibille, R. J. Zitnik, G. Bayles, M. G. Buck and W. W. Merrill
Pulmonary Section, Birmingham Veterans Administration Medical Center, Alabama 35233.

Bronchial inflammation is associated with a reduction in airway caliber. Factors that may dampen this inflammation are ill defined. We have developed a model of airway inflammation using an extract of cotton bracts (CBE). In the current study we characterize inhibitor(s) of polymorphonuclear neutrophil (PMN) function in bronchial lavage (BL) fluid and examine the relationship between inhibitor concentrations and induction of bronchial inflammation or bronchoconstriction by CBE. We report that BL obtained contains factors that inhibit PMN hydrogen peroxide production and chemotaxis to formylmethionylleucyl-phenylalanine (FMLP). In two different subject populations the relative degree of a one molecular mass inhibitor was greatest in BL from subjects that manifested little bronchoconstriction to CBE compared with other subjects. In one subject population the relative amount of this inhibitor correlated inversely with the bronchoconstricting response to CBE and a number of parameters of airway inflammation including PMN noted on bronchial biopsy after CBE instillation. Partial chemical characterization of one molecular mass BL-derived inhibitor reveals it is of low molecular mass (less than 1,000 Da), nonpolar, and sensitive to aminopeptidase digestion. The finding that the bronchial environment contains variable concentrations of an oligopeptide that inhibits PMN function has important implications for treatment of inflammatory airway diseases.

This article has been cited by other articles:

				H. Y. Reynolds Lung Inflammation and Fibrosis: An Alveolar Macrophage-centered Perspective from the 1970s to 1980s Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 98 - 102. [Full Text] [PDF]

				J. A. D. COOPER Jr., A. L. RIDGEWAY, J. PEARSON, and R. R. CULBRETH Attenuation of Interleukin 8-induced Nasal Inflammation by an Inhibitor Peptide Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1198 - 1205. [Abstract] [Full Text]